← Evidence map

ArticleKidney international reports2025

Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [

Kiyotaka Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [ | OpenQuestion